Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...

Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for ...

"This discovery is an important step toward using natural biological tools to improve cancer treatment," says Hanayama, lead author of the study. "By using extracellular vesicles, we can enhance ...

Immunotherapy has revolutionized cancer treatment by harnessing the power of T cells ... alongside an equally vast number of potential antigen targets. Experimentally testing all these combinations is ...

A second phase 1 trial plans to evaluate CER-1236, a novel chimeric antigen receptor therapy, for solid tumors.

Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...